Skip to content
10-K/A

Annual Report

N-Viro International Corporation

0000904896-15-000014

← back to feed
Filed
Apr 29, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Mar 27, 2015 8.55M sh
Long Term Debt FY 2014 · Dec 31, 2014 $6.18K
Long Term Debt FY 2014 · Dec 31, 2013 $32.82K
Capex FY 2014 · Dec 31, 2013 −$4.63K
Operating Cash Flow FY 2014 · Dec 31, 2013 −$93.54K
Short Term Debt FY 2014 · Dec 31, 2013 $92.25K
Current Liabilities FY 2014 · Dec 31, 2013 $2.38M
Total Liabilities FY 2014 · Dec 31, 2013 $2.41M
Current Assets FY 2014 · Dec 31, 2013 $708.03K
Total Assets FY 2014 · Dec 31, 2013 $1.78M
Sga Expense restated FY 2014 · Dec 31, 2013 $2.07M
Net Income FY 2014 · Dec 31, 2013 −$1.65M
Operating Income FY 2014 · Dec 31, 2013 −$1.66M
Gross Profit FY 2014 · Dec 31, 2013 $388.61K
Cost Of Revenue FY 2014 · Dec 31, 2013 $2.99M
Revenue FY 2014 · Dec 31, 2013 $3.38M
Cash And Equivalents FY 2014 · Dec 31, 2012 $52.63K